Chronic Disease Interventions Work And Are Cost Effective

Cost effective for Big Pharma and the sick care industry.

"Low income, developing, and developed countries have shown that chronic disease interventions, such as...multidrug regimens for high-risk cardiovascular disease patients are cost effective and should be increased, according to Dr Thomas Gaziano, Brigham & Women's Hospital, Harvard Program for Health Division Science, Boston, MA, USA, and team, authors of the second paper in The Lancet's Chronic Diseases Series."

You decide.